Below are the financial statements of Nissan Chemical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
All figures in millions of JPY | 2024 | 2023 |
---|---|---|
Current assets | — | — |
Cash and deposits | 22,738b | 29,647b |
Notes and accounts receivable - trade, and contract assets | 88,800b | 82,670b |
Merchandise and finished goods | 56,804b | 46,950b |
Work in process | 5b | 18b |
Raw materials and supplies | 21,370b | 17,703b |
Accounts receivable - other | 2,956b | 2,113b |
Short-term loans receivable | 2,152b | 3,088b |
Other | 7,189b | 7,305b |
Allowance for doubtful accounts | -48b | -44b |
Total current assets | 201,968b | 189,454b |
Property, plant and equipment | — | — |
Buildings and structures | 85,860b | 72,520b |
Accumulated depreciation and impairment loss | -50,898b | -46,567b |
Buildings and structures, net | 34,962b | 25,952b |
Machinery, equipment and vehicles | 170,309b | 151,653b |
Accumulated depreciation and impairment loss | -145,729b | -136,861b |
Machinery, equipment and vehicles, net | 24,579b | 14,792b |
Tools, furniture and fixtures | 44,084b | 42,153b |
Accumulated depreciation and impairment loss | -39,457b | -38,379b |
Tools, furniture and fixtures, net | 4,626b | 3,774b |
Land | 9,064b | 8,817b |
Leased assets | 160b | 149b |
Accumulated depreciation and impairment loss | -24b | -10b |
Leased assets, net | 135b | 139b |
Construction in progress | 4,004b | 11,176b |
Total property, plant and equipment | 77,372b | 64,653b |
Intangible assets | — | — |
Software | 2,444b | 1,722b |
Other | 8,302b | 9,813b |
Total intangible assets | 10,747b | 11,535b |
Investments and other assets | — | — |
Investment securities | 26,119b | 27,322b |
Long-term loans receivable | 50b | 0b |
Deferred tax assets | 519b | 531b |
Net defined benefit asset | 3,737b | 2,140b |
Other | 3,054b | 3,186b |
Allowance for doubtful accounts | -111b | -110b |
Total investments and other assets | 33,370b | 33,071b |
Non-current assets | — | — |
Total non-current assets | 121,489b | 109,260b |
Assets | — | — |
Total assets | 323,458b | 298,715b |
Current liabilities | — | — |
Notes and accounts payable - trade | 20,427b | 19,942b |
Short-term loans payable | 39,062b | 25,327b |
Current portion of long-term loans payable | 634b | 624b |
Income taxes payable | 4,940b | 7,879b |
Provision for bonuses | 2,548b | 2,413b |
Provision for loss on business of subsidiaries and affiliates | 310b | 0b |
Provision for business structure improvement | 2b | 418b |
Other | 18,638b | 15,556b |
Total current liabilities | 86,563b | 72,161b |
Non-current liabilities | — | — |
Long-term loans payable | 1,284b | 1,338b |
Deferred tax liabilities | 1,431b | 98b |
Provision for loss on business of subsidiaries and affiliates | 143b | 626b |
Provision for share-based remuneration for directors (and other officers) | 272b | 256b |
Net defined benefit liability | 467b | 377b |
Other | 2,392b | 2,331b |
Total non-current liabilities | 5,991b | 5,027b |
Liabilities | — | — |
Total liabilities | 92,554b | 77,188b |
Shareholders' equity | — | — |
Capital stock | 18,942b | 18,942b |
Capital surplus | 13,613b | 13,613b |
Retained earnings | 182,327b | 182,400b |
Treasury shares | -943b | -6,111b |
Total shareholders’ equity | 213,939b | 208,844b |
Accumulated other comprehensive income | — | — |
Valuation difference on available-for-sale securities | 8,238b | 7,678b |
Foreign currency translation adjustment | 4,226b | 1,735b |
Remeasurements of defined benefit plans | 1,066b | 159b |
Total accumulated other comprehensive income | 13,531b | 9,574b |
Net assets | — | — |
Non-controlling interests | 3,432b | 3,107b |
Total net assets | 230,903b | 221,526b |
Total liabilities and net assets | 323,458b | 298,715b |
Cash and deposits | 27,454a | 22,738a |
Notes and accounts receivable and contract assets | 89,131a | 88,800a |
Merchandise and finished goods | 57,505a | 56,804a |
Work in process | 19a | 5a |
Raw materials and supplies | 22,624a | 21,370a |
Accrued income | 2,146a | 2,956a |
Short-term loans receivable | 2,257a | 2,152a |
Other | 9,277a | 7,189a |
Allowance for doubtful accounts | -64a | -48a |
Total current assets | 210,352a | 201,968a |
Buildings and structures | 89,171a | 85,860a |
Accumulated depreciation and impairment losses | -55,383a | -50,898a |
Buildings and structures (net) | 33,788a | 34,962a |
Machinery, equipment and vehicles | 176,436a | 170,309a |
Accumulated depreciation and impairment losses | -155,323a | -145,729a |
Machinery, equipment and vehicles (net) | 21,113a | 24,579a |
Tools, furniture and fixtures | 45,732a | 44,084a |
Accumulated depreciation and impairment losses | -41,561a | -39,457a |
Tools, furniture and fixtures (net) | 4,170a | 4,626a |
Land | 8,867a | 9,064a |
Leased assets | 123a | 160a |
Accumulated depreciation and impairment losses | -10a | -24a |
Leased assets (net) | 113a | 135a |
Construction in progress | 4,370a | 4,004a |
Total property, plant and equipment | 72,424a | 77,372a |
Software | 3,511a | 2,444a |
Other | 9,951a | 8,302a |
Total intangible assets | 13,463a | 10,747a |
Investment securities | 24,353a | 26,119a |
Long-term loans receivable | 133a | 50a |
Deferred tax assets | 567a | 519a |
Assets for retirement benefits | 4,782a | 3,737a |
Other | 4,742a | 3,054a |
Allowance for doubtful accounts | -56a | -111a |
Total investments and other assets | 34,523a | 33,370a |
Total non-current assets | 120,411a | 121,489a |
Total assets | 330,763a | 323,458a |
Notes and accounts payable | 19,877a | 20,427a |
Short-term borrowings | 19,987a | 39,062a |
Commercial paper | 8,996a | 0a |
Current portion of long-term borrowings | 514a | 634a |
Income taxes payable | 9,957a | 4,940a |
Provision for bonuses | 2,576a | 2,548a |
Provision for losses of affiliated companies | 213a | 310a |
Provision for business structure improvement | 0a | 2a |
Other | 17,096a | 18,638a |
Total current liabilities | 79,218a | 86,563a |
Bonds payable | 10,000a | 0a |
Long-term borrowings | 977a | 1,284a |
Deferred tax liabilities | 1,063a | 1,381a |
Provision for losses of affiliated companies | 0a | 143a |
Provision for directors' share-based compensation | 264a | 272a |
Liability for retirement benefits | 542a | 467a |
Other | 2,515a | 2,392a |
Total non-current liabilities | 15,363a | 5,941a |
Total liabilities | 94,582a | 92,505a |
Capital stock | 18,942a | 18,942a |
Capital surplus | 13,613a | 13,613a |
Retained earnings | 192,928a | 182,376a |
Treasury stock | -2,590a | -943a |
Total shareholders' equity | 222,893a | 213,989a |
Valuation difference on available-for-sale securities | 7,035a | 8,238a |
Foreign currency translation adjustment | 1,788a | 4,226a |
Remeasurements of defined benefit plans | 1,573a | 1,066a |
Total accumulated other comprehensive income | 10,397a | 13,531a |
Noncontrolling interests | 2,889a | 3,432a |
Total net assets | 236,180a | 230,952a |
Total liabilities and net assets | 330,763a | 323,458a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Nissan Chemical’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.